DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Novantrone (Mitoxantrone Hydrochloride) - Current Clinical Trials

 
 



Novantrone Related Clinical Trials

A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis. [Completed]

Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection [Completed]

Mitoxantrone ´┐Ż Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) [Active, not recruiting]

Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias [Completed]

Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone [Completed]

Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination [Active, not recruiting]

Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients [Active, not recruiting]

Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma [Active, not recruiting]

Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed and Refractory Acute Myeloid Leukemia [Active, not recruiting]

FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years [Active, not recruiting]

Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia [Recruiting]

Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia [Recruiting]

CIP-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma [Not yet recruiting]

Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia [Recruiting]

Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer [Recruiting]

Ixabepilone, Mitoxantrone Hydrochloride, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy and Chemotherapy [Completed]

CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Active, not recruiting]

Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Terminated]

Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell [Completed]

Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Recruiting]

Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Completed]

Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis [Active, not recruiting]

Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia [Completed]

Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia [Completed]

Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Completed]

Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC) [Terminated]

Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation [Terminated]

Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Treating Relapsed or Refractory Acute Myeloid Leukemia [Recruiting]

AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia [Completed]

Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders [Recruiting]

Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma [Completed]

Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas [Completed]

Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia [Completed]

Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer [Completed]

Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma [Active, not recruiting]

A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC) [Terminated]

Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma [Completed]

Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer [Terminated]

Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Recruiting]

Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma [Completed]

IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML) [Terminated]

Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer [Completed]

Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma [Not yet recruiting]

A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer [Completed]

Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma [Terminated]

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer [Terminated]

Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Completed]

Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence [Withdrawn]

XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer [Completed]

Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) [Active, not recruiting]

A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia [Terminated]

Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia [Completed]

Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma [Completed]

Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab [Terminated]

Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC [Completed]

Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients [Completed]

Study Evaluating Mitoxantrone in Multiple Sclerosis [Terminated]

Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Suspended]

Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia [Terminated]

Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia [Active, not recruiting]

Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer [Completed]

AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer [Completed]

R-BMD GELTAMO Relapsed Lymphoma [Active, not recruiting]

Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Completed]

Study of VELCADE« With Mitoxantrone and Etoposide for Leukemias [Completed]

Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer [Completed]

S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy [Completed]

Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia [Completed]

Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma [Terminated]

Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Active, not recruiting]

Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer [Completed]

Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer [Completed]

Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer [Completed]

Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma [Completed]

Impact Study of 2 Therapeutic Strategy for Aggressive Remitting Multiple Sclerosis [Recruiting]

Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer [Active, not recruiting]

Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) [Completed]

Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer [Active, not recruiting]

Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia [Completed]

Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer [Active, not recruiting]

Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas [Completed]

High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML [Completed]

Study of Irofulven in Patients With Hormone-refractory Prostate Cancer [Active, not recruiting]

Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers [Completed]

Alvocidib (Flavopiridol), Ara-C and Mitoxantrone (FLAM) Versus "7+3" for Newly (AML) [Active, not recruiting]

Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) [Active, not recruiting]

Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma [Active, not recruiting]

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma [Not yet recruiting]

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome [Not yet recruiting]

A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis [Completed]

Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis [Terminated]

A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017